The prevalence of and factors influencing statistical testing of baseline characteristics in randomized controlled trials published in high-impact orthodontic journals.


Journal

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
ISSN: 1097-6752
Titre abrégé: Am J Orthod Dentofacial Orthop
Pays: United States
ID NLM: 8610224

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 01 07 2022
revised: 01 12 2022
accepted: 01 12 2022
pubmed: 5 1 2023
medline: 8 3 2023
entrez: 4 1 2023
Statut: ppublish

Résumé

When proper randomization has been undertaken, statistical testing of baseline characteristics between participants in trial arms in randomized controlled trials (RCTs) is not required. This investigation aimed to assess the prevalence of statistical testing of baseline differences in orthodontic RCTs. Factors influencing the undertaking of this analysis were explored. Orthodontic RCTs published between January 1, 2017 and December 31, 2021 in 5 orthodontic journals were identified. To determine if statistical testing of baseline differences had been undertaken, each article was reviewed in detail to identify the reporting of P values and the term "significant difference" in the table of characteristics, the table legends, and the results section of each included RCT. Trial characteristics at the RCT level were extracted. Frequency distributions were calculated for the included trial characteristics. Significant predictors from the univariate analysis were used to construct a multivariable Bayesian logistic regression model. One hundred and thirty-two RCTs were analyzed. Significance testing of baseline characteristics was undertaken in 50% (66/132) of RCTs. At a journal level, significance testing at baseline was infrequently undertaken in RCTs published in the American Journal of Orthodontics and Dentofacial Orthopedics (AJODO). Compared with 2017, RCTs published in 2018 (odds ratio [OR], 5.57; 95% credible interval [CrI], 1.33-25.69), 2019 (OR, 17.82; 95% CrI, 4.41-82.11), 2020 (OR, 6.48; 95% CrI, 1.72-27.12), and 2021 (OR, 3.24, 95% CrI, 0.81-14.01) had higher odds of significance testing at baseline. RCTs published in the European Journal of Orthodontics (OR, 5.31; 95% CrI, 1.79-17.04), Progress in Orthodontics (OR, 5.00; 95% CrI, 0.97-28.43), Orthodontics and Craniofacial Research (OR, 6.49; 95% CrI, 1.04-46.10), and Angle Orthodontist (OR, 12.30; 95% CrI, 3.27-51.44) had higher odds of significant testing at baseline testing compared with AJODO. Statistical testing of baseline differences is common in orthodontic RCTs. Trials published in AJODO had the lowest incidence of statistical testing of baseline differences. RCTs published between 2018-2021 had higher odds of significance testing at baseline than in 2017. Per the consolidated standards of reporting trials guidelines, this practice should be discouraged as it can be misleading and unnecessary.

Identifiants

pubmed: 36599785
pii: S0889-5406(22)00783-1
doi: 10.1016/j.ajodo.2022.12.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34-e83

Informations de copyright

Copyright © 2022 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.

Auteurs

Amal Alduwaisan (A)

Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom; Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom.

Lorna Hirst (L)

Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Kings College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom.

Martyn T Cobourne (MT)

Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom; Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom; Centre for Craniofacial Development & Regeneration, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Guy's Hospital, London, United Kingdom.

Nikolaos Pandis (N)

Department of Orthodontics and Dentofacial Orthopedics, Dental School/Medical Faculty, University of Bern, Bern, Switzerland.

Jadbinder Seehra (J)

Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom; Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom; Centre for Craniofacial Development & Regeneration, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Guy's Hospital, London, United Kingdom. Electronic address: jadbinderpal.seehra@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH